基于药房的即时检验：“医疗护理标准”方法如何促进可持续性。
Pharmacy-Based Point-of-Care Testing: How a "Standard of Care" Approach Can Facilitate Sustainability.
作者信息
Adams Alex J, Klepser Donald G, Klepser Michael E, Adams Jennifer L
机构信息
Idaho Division of Financial Management.
University of Nebraska Medical Center, College of Pharmacy.
出版信息
Innov Pharm. 2021 Sep 22;12(4). doi: 10.24926/iip.v12i4.4290. eCollection 2021.
Abstract
COVID-19 spurred rapid expansion of pharmacy-based point-of-care testing (POCT). This growth was aided, in part, by federal guidance that removed state-level regulatory uncertainty surrounding the ability of pharmacists to administer, interpret, and act on the results of tests. Surveys suggest there is considerable confusion about the legality of these services by state regulators. To ensure the sustainability of POCT services over time, states should consider adopting a standard of care approach to regulation, allowing a flexible framework for practice innovation and expansion over time.
摘要
新冠疫情促使基于药房的即时检验（POCT）迅速扩张。这一增长部分得益于联邦指导意见，该意见消除了各州层面围绕药剂师进行检测、解读检测结果并据此采取行动的能力的监管不确定性。调查显示，州监管机构对这些服务的合法性存在相当大的困惑。为确保即时检验服务长期可持续，各州应考虑采用护理标准监管方法，允许随着时间推移形成一个灵活的实践创新与扩张框架。
相似文献
1
Pharmacy-Based Point-of-Care Testing: How a "Standard of Care" Approach Can Facilitate Sustainability.
Innov Pharm. 2021 Sep 22;12(4). doi: 10.24926/iip.v12i4.4290. eCollection 2021.
2
Training student pharmacists to facilitate human immunodeficiency virus point-of-care testing.
Curr Pharm Teach Learn. 2020 Oct;12(10):1245-1251. doi: 10.1016/j.cptl.2020.05.004. Epub 2020 Jun 11.
3
Expanding access to HIV testing through Canadian community pharmacies: findings from the APPROACH study.
BMC Public Health. 2020 May 7;20(1):639. doi: 10.1186/s12889-020-08719-0.
4
Potential for Pharmacy-Public Health Collaborations Using Pharmacy-Based Point-of-Care Testing Services for Infectious Diseases.
J Public Health Manag Pract. 2017 Nov/Dec;23(6):593-600. doi: 10.1097/PHH.0000000000000482.
5
A state-level needs analysis of community pharmacy point-of-care testing.
J Am Pharm Assoc (2003). 2021 May-Jun;61(3):e93-e98. doi: 10.1016/j.japh.2020.12.013. Epub 2021 Jan 9.
6
Adaptation of POCT for pharmacies to reduce risk and optimize access to care in HIV, the APPROACH study protocol: examining acceptability and feasibility.
Pilot Feasibility Stud. 2018 Feb 27;4:59. doi: 10.1186/s40814-018-0252-1. eCollection 2018.
7
Implementing community pharmacy-based influenza point-of-care test-and-treat under collaborative practice agreement.
Implement Sci Commun. 2022 Jul 16;3(1):77. doi: 10.1186/s43058-022-00324-z.
8
Point-of-care testing in pharmacies-An evaluation of the service from the lens of resource-based theory of competitive advantage.
J Am Pharm Assoc (2003). 2021 Mar-Apr;61(2):e45-e54. doi: 10.1016/j.japh.2020.11.005. Epub 2020 Dec 9.
9
Pharmacy Technicians and Point of Care Testing.
J Pharm Technol. 2015 Aug;31(4):143-148. doi: 10.1177/8755122515579106. Epub 2015 Mar 23.
10
Pharmacists' Opinions on the Implementation of HIV and HepC Point-of-Care-Testing in a U.S. Pharmacy Chain.
Innov Pharm. 2019 Aug 31;10(1). doi: 10.24926/iip.v10i1.1425. eCollection 2019.
引用本文的文献
1
Regulating pharmacist services: Achieving a full scope of practice.
Can Pharm J (Ott). 2023 Jul 25;156(5):231-234. doi: 10.1177/17151635231188330. eCollection 2023 Sep-Oct.
2
Implementation of the California advanced practice pharmacist and the continued disappointment of tiered licensure.
Explor Res Clin Soc Pharm. 2023 Oct 20;12:100353. doi: 10.1016/j.rcsop.2023.100353. eCollection 2023 Dec.
3
Extending COVID-19 Pharmacy Technician Duties: Impact on Safety and Pharmacist Jobs.
J Pharm Technol. 2023 Jun;39(3):134-138. doi: 10.1177/87551225231172343. Epub 2023 May 24.
本文引用的文献
1
Does Increased State Pharmacy Regulatory Burden Lead to Better Public Safety Outcomes?
Innov Pharm. 2021 Mar 2;12(1). doi: 10.24926/iip.v12i1.3598. eCollection 2021.
2
Pharmacists' Patient Care Process: A State "Scope of Practice" Perspective.
Innov Pharm. 2019 Aug 31;10(2). doi: 10.24926/iip.v10i2.1389. eCollection 2019.
3
Impact of COVID-19 on prevalence of community pharmacies as CLIA-Waived facilities.
Res Social Adm Pharm. 2021 Sep;17(9):1574-1578. doi: 10.1016/j.sapharm.2020.12.003. Epub 2020 Dec 15.
4
Pharmacists' Patient Care Process: State "Scope of Practice" Priorities for Action.
Ann Pharmacother. 2021 Apr;55(4):549-555. doi: 10.1177/1060028020950193. Epub 2020 Aug 13.
5
Pharmacist Prescriptive Authority: Lessons from Idaho.
Pharmacy (Basel). 2020 Jul 8;8(3):112. doi: 10.3390/pharmacy8030112.
6
Moving the Needle: A 50-State and District of Columbia Landscape Review of Laws Regarding Pharmacy Technician Vaccine Administration.
Pharmacy (Basel). 2019 Dec 10;7(4):168. doi: 10.3390/pharmacy7040168.
7
Transitioning pharmacy to "standard of care" regulation: Analyzing how pharmacy regulates relative to medicine and nursing.
Res Social Adm Pharm. 2019 Oct;15(10):1230-1235. doi: 10.1016/j.sapharm.2018.10.008. Epub 2018 Oct 16.
8
The Roles of Pharmacy Schools in Bridging the Gap Between Law and Practice.
Am J Pharm Educ. 2018 May;82(4):6577. doi: 10.5688/ajpe6577.
9
Clinical service implementation in the face of initial regulatory uncertainty.
J Am Pharm Assoc (2003). 2016 Sep-Oct;56(5):492. doi: 10.1016/j.japh.2016.04.563.
10
The Continuum of Pharmacist Prescriptive Authority.
Ann Pharmacother. 2016 Sep;50(9):778-84. doi: 10.1177/1060028016653608. Epub 2016 Jun 15.
Zotero 插件